US 11965161
Methods and compositions for sensitization of tumor cells to immune therapy
granted A61KA61K45/06
Quick answer
US patent 11965161 (Methods and compositions for sensitization of tumor cells to immune therapy) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K45/06